PP Leone, A Scotti, EC Ho, M Assafin… - Journal of clinical …, 2023 - mdpi.com
Transcatheter aortic valve implantation (TAVI) has risen over the past 20 years as a safe and effective alternative to surgical aortic valve replacement for treatment of severe aortic …
Primary or secondary tricuspid regurgitation (TR) represents an important health care burden and challenge which has often been neglected or undertreated in the past. The …
P Deharo, A Bisson, J Herbert, T Lacour… - Circulation, 2020 - Am Heart Assoc
Background: Two competing transcatheter aortic valve replacement (TAVR) technologies are currently available. Head-to-head comparisons of the relative performances of these 2 …
H Möllmann, DM Holzhey, M Hilker… - Clinical Research in …, 2021 - Springer
Background Transcatheter aortic valve implantation (TAVI) has become standard treatment for elderly patients with symptomatic severe aortic valve stenosis. The ACURATE neo AS …
A Scotti, M Pagnesi, WK Kim, U Schäfer… - …, 2022 - ncbi.nlm.nih.gov
Background Transcatheter aortic valve replacement (TAVR) with the ACURATE neo device has been associated with a non-negligible incidence of paravalvular aortic regurgitation …
D Regazzoli, M Chiarito, F Cannata, M Pagnesi… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to evaluate and compare the outcomes of transcatheter self-expandable prostheses in patients with small annuli. Background Transcatheter aortic …
M Pagnesi, WK Kim, S Baggio, A Scotti… - Cardiovascular …, 2023 - jacc.org
Objectives The authors sought to evaluate the incidence, predictors, and outcomes of new permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement …
G Costa, F Saia, T Pilgrim, M Abdel-Wahab… - Cardiovascular …, 2022 - jacc.org
Background The latest iterations of devices for transcatheter aortic valve replacement (TAVR) have brought refinements to further improve patient outcomes. Objectives This study …
BE Claessen, GHL Tang, AS Kini, SK Sharma - JAMA cardiology, 2021 - jamanetwork.com
Importance Aortic valve stenosis (AS) is the most common manifestation of acquired valvular heart disease in developed countries. Several large-scale randomized clinical trials …